25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

PHX (Pharmx) Stock Analysis
Buy, Hold or Sell?

Let's analyze Pharmx together

I guess you are interested in Pharmx Technologies Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Pharmx’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Pharmx’s Price Targets

I'm going to help you getting a better view of Pharmx Technologies Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Pharmx Technologies Ltd

I send you an email if I find something interesting about Pharmx Technologies Ltd.

1. Quick Overview

1.1. Quick analysis of Pharmx (30 sec.)










1.2. What can you expect buying and holding a share of Pharmx? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
A$0.03
Expected worth in 1 year
A$-0.02
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$-0.04
Return On Investment
-45.3%

For what price can you sell your share?

Current Price per Share
A$0.09
Expected price per share
A$0.085 - A$0.097
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Pharmx (5 min.)




Live pricePrice per Share (EOD)
A$0.09
Intrinsic Value Per Share
A$-0.05 - A$0.13
Total Value Per Share
A$-0.02 - A$0.15

2.2. Growth of Pharmx (5 min.)




Is Pharmx growing?

Current yearPrevious yearGrowGrow %
How rich?$10.4m$14.5m-$4m-39.1%

How much money is Pharmx making?

Current yearPrevious yearGrowGrow %
Making money-$1.1m-$688.9k-$470.6k-40.6%
Net Profit Margin-27.3%-17.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Pharmx (5 min.)




2.4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Pharmx?

Welcome investor! Pharmx's management wants to use your money to grow the business. In return you get a share of Pharmx.

First you should know what it really means to hold a share of Pharmx. And how you can make/lose money.

Speculation

The Price per Share of Pharmx is A$0.092. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pharmx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pharmx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.03. Based on the TTM, the Book Value Change Per Share is A$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pharmx.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-2.1%0.00-2.1%0.00-1.3%0.00-1.0%0.00-0.3%0.00-0.8%
Usd Book Value Change Per Share-0.01-7.4%-0.01-7.4%0.00-1.2%0.00-2.8%0.001.4%0.00-0.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.4%0.000.8%
Usd Total Gains Per Share-0.01-7.4%-0.01-7.4%0.00-1.2%0.00-2.8%0.001.8%0.000.4%
Usd Price Per Share0.02-0.02-0.02-0.02-0.03-0.04-
Price to Earnings Ratio-12.86--12.86--21.07-15.61-46.66-261.21-
Price-to-Total Gains Ratio-3.65--3.65--22.32-16.19-11.89--262.94-
Price to Book Ratio1.42-1.42-1.00-1.10-1.48-1.92-
Price-to-Total Gains Ratio-3.65--3.65--22.32-16.19-11.89--262.94-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.060306
Number of shares16582
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (16582 shares)-113.3128.12
Gains per Year (16582 shares)-453.23112.48
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-453-4632686102
20-906-91652173214
30-1360-136978259326
40-1813-1822104346438
50-2266-2275130432550
60-2719-2728156519662
70-3173-3181182605774
80-3626-3634208692886
90-4079-4087234778998
100-4532-45402608641110

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%6.04.00.060.0%13.014.06.039.4%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%5.05.00.050.0%18.015.00.054.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%2.00.03.040.0%5.00.05.050.0%11.00.022.033.3%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%5.05.00.050.0%18.015.00.054.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Pharmx Technologies Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.010-0.0100%-0.002-84%-0.004-63%0.002-624%0.000-95%
Book Value Per Share--0.0270.0270%0.037-28%0.034-22%0.033-18%0.029-9%
Current Ratio--1.3701.3700%1.838-25%1.629-16%1.663-18%1.888-27%
Debt To Asset Ratio--0.4650.4650%0.392+19%0.368+27%0.337+38%0.309+50%
Debt To Equity Ratio--0.8690.8690%0.644+35%0.613+42%0.532+63%0.464+88%
Dividend Per Share----0%-0%-0%0.001-100%0.001-100%
Enterprise Value--8858266.3048858266.3040%20641759.296-57%16014087.957-45%23786891.899-63%32877723.100-73%
Eps---0.003-0.0030%-0.002-41%-0.001-52%0.000-85%-0.001-63%
Ev To Sales Ratio--1.3661.3660%3.430-60%2.117-35%2.515-46%2.640-48%
Free Cash Flow Per Share--0.0030.0030%-0.006+307%-0.002+172%-0.004+234%-0.003+214%
Free Cash Flow To Equity Per Share---0.005-0.0050%-0.006+23%-0.005-2%-0.002-60%-0.001-75%
Gross Profit Margin--1.0001.0000%1.164-14%0.705+42%0.255+293%-1.548+255%
Intrinsic Value_10Y_max--0.126----------
Intrinsic Value_10Y_min---0.051----------
Intrinsic Value_1Y_max--0.001----------
Intrinsic Value_1Y_min---0.004----------
Intrinsic Value_3Y_max--0.012----------
Intrinsic Value_3Y_min---0.013----------
Intrinsic Value_5Y_max--0.034----------
Intrinsic Value_5Y_min---0.023----------
Market Cap55062644.736+59%22743266.30422743266.3040%22144759.296+3%21745754.624+5%28345291.899-20%34426123.100-34%
Net Profit Margin---0.273-0.2730%-0.175-36%-0.142-48%-0.064-76%-0.089-67%
Operating Margin----0%-0.1110%-0.0270%0.051-100%0.077-100%
Operating Ratio--0.1900.1900%1.177-84%0.840-77%0.948-80%0.957-80%
Pb Ratio3.447+59%1.4241.4240%0.997+43%1.099+30%1.484-4%1.922-26%
Pe Ratio-31.126-142%-12.857-12.8570%-21.070+64%15.608-182%46.659-128%261.211-105%
Price Per Share0.092+59%0.0380.0380%0.037+3%0.036+5%0.047-20%0.058-34%
Price To Free Cash Flow Ratio33.926+59%14.01314.0130%-6.593+147%-1.333+110%-4.834+134%-4.562+133%
Price To Total Gains Ratio-8.826-142%-3.645-3.6450%-22.323+512%16.190-123%11.894-131%-262.938+7113%
Quick Ratio--0.0830.0830%2.139-96%1.529-95%1.372-94%1.408-94%
Return On Assets---0.059-0.0590%-0.029-51%-0.027-55%-0.007-88%-0.043-28%
Return On Equity---0.111-0.1110%-0.047-57%-0.049-56%-0.017-84%-0.068-39%
Total Gains Per Share---0.010-0.0100%-0.002-84%-0.004-63%0.003-503%0.001-1889%
Usd Book Value--10469646.00010469646.0000%14559310.500-28%13412841.000-22%12783954.300-18%11509072.350-9%
Usd Book Value Change Per Share---0.007-0.0070%-0.001-84%-0.003-63%0.001-624%0.000-95%
Usd Book Value Per Share--0.0170.0170%0.024-28%0.022-22%0.021-18%0.019-9%
Usd Dividend Per Share----0%-0%-0%0.000-100%0.001-100%
Usd Enterprise Value--5806593.5625806593.5620%13530673.219-57%10497234.656-45%15592307.640-63%21551347.492-73%
Usd Eps---0.002-0.0020%-0.001-41%-0.001-52%0.000-85%-0.001-63%
Usd Free Cash Flow--1063876.5001063876.5000%-2201824.500+307%-768683.000+172%-1427810.100+234%-1212543.900+214%
Usd Free Cash Flow Per Share--0.0020.0020%-0.004+307%-0.001+172%-0.002+234%-0.002+214%
Usd Free Cash Flow To Equity Per Share---0.003-0.0030%-0.004+23%-0.003-2%-0.001-60%-0.001-75%
Usd Market Cap36093563.624+59%14908211.06214908211.0620%14515889.719+3%14254342.156+5%18580338.840-20%22566323.692-34%
Usd Price Per Share0.060+59%0.0250.0250%0.024+3%0.024+5%0.031-20%0.038-34%
Usd Profit---1159579.500-1159579.5000%-688930.500-41%-561108.000-52%-170561.100-85%-424436.250-63%
Usd Revenue--4252228.5004252228.5000%3944799.000+8%5337299.500-20%6062457.300-30%7506196.050-43%
Usd Total Gains Per Share---0.007-0.0070%-0.001-84%-0.003-63%0.002-503%0.000-1889%
 EOD+4 -4MRQTTM+0 -0YOY+11 -253Y+9 -275Y+8 -3110Y+9 -30

3.3 Fundamental Score

Let's check the fundamental score of Pharmx Technologies Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-31.126
Price to Book Ratio (EOD)Between0-13.447
Net Profit Margin (MRQ)Greater than0-0.273
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.083
Current Ratio (MRQ)Greater than11.370
Debt to Asset Ratio (MRQ)Less than10.465
Debt to Equity Ratio (MRQ)Less than10.869
Return on Equity (MRQ)Greater than0.15-0.111
Return on Assets (MRQ)Greater than0.05-0.059
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Pharmx Technologies Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.194
Ma 20Greater thanMa 500.092
Ma 50Greater thanMa 1000.084
Ma 100Greater thanMa 2000.081
OpenGreater thanClose0.091
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Pharmx Technologies Ltd

PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. It also operates PharmX, an electronic ordering gateway; PharmX Marketplace, an online sales and marketing platform; and PharmX Analytics which provides insights for operations of supplier and pharmacy customers. The company was formerly known as Corum Group Limited and changed its name to PharmX Technologies Limited in October 2023. PharmX Technologies Limited was incorporated in 1950 and is headquartered in Sydney, Australia.

Fundamental data was last updated by Penke on 2025-06-26 09:59:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Pharmx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Pharmx to theΒ Health Information Services industry mean.
  • A Net Profit Margin of -27.3%Β means thatΒ $-0.27 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pharmx Technologies Ltd:

  • The MRQ is -27.3%. The company is making a huge loss. -2
  • The TTM is -27.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-27.3%TTM-27.3%0.0%
TTM-27.3%YOY-17.5%-9.8%
TTM-27.3%5Y-6.4%-20.9%
5Y-6.4%10Y-8.9%+2.5%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.3%-10.0%-17.3%
TTM-27.3%-16.3%-11.0%
YOY-17.5%-12.4%-5.1%
3Y-14.2%-23.4%+9.2%
5Y-6.4%-20.4%+14.0%
10Y-8.9%-30.3%+21.4%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Pharmx is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Pharmx to theΒ Health Information Services industry mean.
  • -5.9% Return on Assets means thatΒ Pharmx generatedΒ $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pharmx Technologies Ltd:

  • The MRQ is -5.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.9%TTM-5.9%0.0%
TTM-5.9%YOY-2.9%-3.0%
TTM-5.9%5Y-0.7%-5.2%
5Y-0.7%10Y-4.3%+3.6%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.9%-2.7%-3.2%
TTM-5.9%-4.4%-1.5%
YOY-2.9%-3.7%+0.8%
3Y-2.7%-5.6%+2.9%
5Y-0.7%-5.0%+4.3%
10Y-4.3%-5.5%+1.2%
4.3.1.3. Return on Equity

Shows how efficient Pharmx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Pharmx to theΒ Health Information Services industry mean.
  • -11.1% Return on Equity means Pharmx generated $-0.11Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pharmx Technologies Ltd:

  • The MRQ is -11.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -11.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.1%TTM-11.1%0.0%
TTM-11.1%YOY-4.7%-6.3%
TTM-11.1%5Y-1.7%-9.3%
5Y-1.7%10Y-6.8%+5.0%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.1%-1.7%-9.4%
TTM-11.1%-3.2%-7.9%
YOY-4.7%-3.2%-1.5%
3Y-4.9%-6.7%+1.8%
5Y-1.7%-8.0%+6.3%
10Y-6.8%-9.5%+2.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Pharmx Technologies Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Pharmx is operatingΒ .

  • Measures how much profit Pharmx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Pharmx to theΒ Health Information Services industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pharmx Technologies Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-11.1%+11.1%
TTM-5Y5.1%-5.1%
5Y5.1%10Y7.7%-2.6%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.2%+14.2%
TTM--11.5%+11.5%
YOY-11.1%-9.5%-1.6%
3Y-2.7%-12.5%+9.8%
5Y5.1%-10.6%+15.7%
10Y7.7%-24.8%+32.5%
4.3.2.2. Operating Ratio

Measures how efficient Pharmx is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Health Information Services industry mean).
  • An Operation Ratio of 0.19 means that the operating costs are $0.19 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Pharmx Technologies Ltd:

  • The MRQ is 0.190. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.190. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.190TTM0.1900.000
TTM0.190YOY1.177-0.987
TTM0.1905Y0.948-0.757
5Y0.94810Y0.957-0.009
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1901.326-1.136
TTM0.1901.334-1.144
YOY1.1771.343-0.166
3Y0.8401.348-0.508
5Y0.9481.342-0.394
10Y0.9571.304-0.347
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Pharmx Technologies Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Pharmx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Health Information Services industry mean).
  • A Current Ratio of 1.37Β means the company has $1.37 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Pharmx Technologies Ltd:

  • The MRQ is 1.370. The company is just able to pay all its short-term debts.
  • The TTM is 1.370. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.370TTM1.3700.000
TTM1.370YOY1.838-0.468
TTM1.3705Y1.663-0.293
5Y1.66310Y1.888-0.226
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3701.682-0.312
TTM1.3701.562-0.192
YOY1.8381.806+0.032
3Y1.6291.960-0.331
5Y1.6632.666-1.003
10Y1.8882.526-0.638
4.4.3.2. Quick Ratio

Measures if Pharmx is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Pharmx to theΒ Health Information Services industry mean.
  • A Quick Ratio of 0.08Β means the company can pay off $0.08 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pharmx Technologies Ltd:

  • The MRQ is 0.083. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.083. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.083TTM0.0830.000
TTM0.083YOY2.139-2.056
TTM0.0835Y1.372-1.289
5Y1.37210Y1.408-0.036
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0831.037-0.954
TTM0.0831.061-0.978
YOY2.1391.276+0.863
3Y1.5291.445+0.084
5Y1.3722.069-0.697
10Y1.4082.129-0.721
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Pharmx Technologies Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of PharmxΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Pharmx to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.47Β means that Pharmx assets areΒ financed with 46.5% credit (debt) and the remaining percentage (100% - 46.5%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Pharmx Technologies Ltd:

  • The MRQ is 0.465. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.465. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.465TTM0.4650.000
TTM0.465YOY0.392+0.073
TTM0.4655Y0.337+0.128
5Y0.33710Y0.309+0.027
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4650.409+0.056
TTM0.4650.406+0.059
YOY0.3920.375+0.017
3Y0.3680.395-0.027
5Y0.3370.400-0.063
10Y0.3090.405-0.096
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Pharmx is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Pharmx to theΒ Health Information Services industry mean.
  • A Debt to Equity ratio of 86.9% means that company has $0.87 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pharmx Technologies Ltd:

  • The MRQ is 0.869. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.869. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.869TTM0.8690.000
TTM0.869YOY0.644+0.225
TTM0.8695Y0.532+0.337
5Y0.53210Y0.464+0.068
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8690.609+0.260
TTM0.8690.608+0.261
YOY0.6440.571+0.073
3Y0.6130.610+0.003
5Y0.5320.629-0.097
10Y0.4640.636-0.172
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Pharmx generates.

  • Above 15 is considered overpriced butΒ always compareΒ Pharmx to theΒ Health Information Services industry mean.
  • A PE ratio of -12.86 means the investor is paying $-12.86Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pharmx Technologies Ltd:

  • The EOD is -31.126. Based on the earnings, the company is expensive. -2
  • The MRQ is -12.857. Based on the earnings, the company is expensive. -2
  • The TTM is -12.857. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-31.126MRQ-12.857-18.270
MRQ-12.857TTM-12.8570.000
TTM-12.857YOY-21.070+8.214
TTM-12.8575Y46.659-59.516
5Y46.65910Y261.211-214.551
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-31.126-1.632-29.494
MRQ-12.857-1.758-11.099
TTM-12.857-1.176-11.681
YOY-21.070-1.951-19.119
3Y15.608-2.962+18.570
5Y46.659-3.179+49.838
10Y261.211-2.271+263.482
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pharmx Technologies Ltd:

  • The EOD is 33.926. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 14.013. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 14.013. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD33.926MRQ14.013+19.913
MRQ14.013TTM14.0130.000
TTM14.013YOY-6.593+20.606
TTM14.0135Y-4.834+18.847
5Y-4.83410Y-4.562-0.272
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD33.926-0.470+34.396
MRQ14.013-0.527+14.540
TTM14.013-1.238+15.251
YOY-6.593-1.936-4.657
3Y-1.333-4.465+3.132
5Y-4.834-6.383+1.549
10Y-4.562-4.194-0.368
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Pharmx is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Health Information Services industry mean).
  • A PB ratio of 1.42 means the investor is paying $1.42Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Pharmx Technologies Ltd:

  • The EOD is 3.447. Based on the equity, the company is fair priced.
  • The MRQ is 1.424. Based on the equity, the company is underpriced. +1
  • The TTM is 1.424. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.447MRQ1.424+2.024
MRQ1.424TTM1.4240.000
TTM1.424YOY0.997+0.427
TTM1.4245Y1.484-0.060
5Y1.48410Y1.922-0.438
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD3.4471.801+1.646
MRQ1.4241.731-0.307
TTM1.4241.754-0.330
YOY0.9972.524-1.527
3Y1.0992.550-1.451
5Y1.4843.496-2.012
10Y1.9224.293-2.371
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Pharmx Technologies Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Research Development  58827615-184431-34685-229-144



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets29,857
Total Liabilities13,885
Total Stockholder Equity15,972
 As reported
Total Liabilities 13,885
Total Stockholder Equity+ 15,972
Total Assets = 29,857

Assets

Total Assets29,857
Total Current Assets16,369
Long-term Assets13,488
Total Current Assets
Cash And Cash Equivalents 13,136
Net Receivables 997
Other Current Assets 79
Total Current Assets  (as reported)16,369
Total Current Assets  (calculated)14,212
+/- 2,157
Long-term Assets
Property Plant Equipment 243
Goodwill 2,115
Intangible Assets 10,815
Long-term Assets Other 92
Long-term Assets  (as reported)13,488
Long-term Assets  (calculated)13,265
+/- 223

Liabilities & Shareholders' Equity

Total Current Liabilities11,950
Long-term Liabilities1,935
Total Stockholder Equity15,972
Total Current Liabilities
Accounts payable 569
Total Current Liabilities  (as reported)11,950
Total Current Liabilities  (calculated)569
+/- 11,381
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt240
Long-term Liabilities  (as reported)1,935
Long-term Liabilities  (calculated)240
+/- 1,695
Total Stockholder Equity
Total Stockholder Equity (as reported)15,972
Total Stockholder Equity (calculated)0
+/- 15,972
Other
Capital Stock93,970
Common Stock Shares Outstanding 598,507
Net Invested Capital 15,972
Net Working Capital 4,419
Property Plant and Equipment Gross 400



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-301997-06-301995-06-301994-06-301993-06-301992-06-301991-06-301990-06-301989-06-30
> Total Assets 
5,284
5,913
6,631
6,606
9,948
14,607
10,644
17,802
14,595
18,033
7,902
23,576
13,699
10,808
10,319
8,011
23,077
26,776
27,013
19,011
19,801
19,888
20,280
25,316
27,244
27,254
26,029
19,757
19,726
15,038
19,178
31,347
30,769
36,520
29,857
29,85736,52030,76931,34719,17815,03819,72619,75726,02927,25427,24425,31620,28019,88819,80119,01127,01326,77623,0778,01110,31910,80813,69923,5767,90218,03314,59517,80210,64414,6079,9486,6066,6315,9135,284
   > Total Current Assets 
1,532
2,205
2,306
2,171
2,270
6,867
4,296
7,752
4,352
1,915
1,660
2,790
4,322
2,829
4,605
3,383
5,582
7,548
7,070
5,002
6,062
7,370
8,944
14,111
16,075
14,851
12,670
12,415
11,154
9,188
9,841
10,416
8,586
22,589
16,369
16,36922,5898,58610,4169,8419,18811,15412,41512,67014,85116,07514,1118,9447,3706,0625,0027,0707,5485,5823,3834,6052,8294,3222,7901,6601,9154,3527,7524,2966,8672,2702,1712,3062,2051,532
       Cash And Cash Equivalents 
1,017
1,400
1,286
1,771
423
623
119
7,666
4,193
1,167
317
393
1,777
24
1,768
1,614
3,643
3,898
5,400
701
4,764
2,110
3,217
8,884
11,913
12,069
9,577
8,098
4,971
2,333
2,323
6,478
5,759
12,806
13,136
13,13612,8065,7596,4782,3232,3334,9718,0989,57712,06911,9138,8843,2172,1104,7647015,4003,8983,6431,6141,768241,7773933171,1674,1937,6661196234231,7711,2861,4001,017
       Short-term Investments 
0
0
0
0
0
796
246
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,252
12,536
0
012,5365,252000000000000000000000000024679600000
       Net Receivables 
515
805
920
400
1,729
4,424
3,595
85
160
569
1,074
1,793
1,608
1,763
2,289
1,330
1,501
3,027
1,353
614
959
527
543
355
158
382
361
393
1,542
2,305
3,826
864
1,085
946
997
9979461,0858643,8262,3051,5423933613821583555435279596141,3533,0271,5011,3302,2891,7631,6081,7931,074569160853,5954,4241,729400920805515
       Other Current Assets 
0
0
100
0
0
174
130
0
0
89
154
3
161
576
414
244
365
521
208
3,542
231
4,627
5,022
4,774
3,882
2,239
2,638
3,775
4,539
2,018
1,822
1,194
1,700
7,178
79
797,1781,7001,1941,8222,0184,5393,7752,6382,2393,8824,7745,0224,6272313,542208521365244414576161315489001301740010000
   > Long-term Assets 
3,752
3,708
4,325
4,435
7,678
7,740
6,348
10,051
10,243
16,118
6,242
20,786
9,377
7,979
5,714
4,628
17,495
19,228
19,943
14,009
13,739
12,518
11,336
11,205
11,169
12,403
13,359
7,342
8,572
5,850
9,337
20,931
22,183
13,931
13,488
13,48813,93122,18320,9319,3375,8508,5727,34213,35912,40311,16911,20511,33612,51813,73914,00919,94319,22817,4954,6285,7147,9799,37720,7866,24216,11810,24310,0516,3487,7407,6784,4354,3253,7083,752
       Property Plant Equipment 
3,752
3,708
4,325
4,313
6,517
6,663
6,348
51
243
651
1,272
1,596
1,377
1,174
780
662
767
907
4,510
2,995
2,778
1,567
383
262
187
294
1,327
981
863
731
1,227
791
603
47
243
243476037911,2277318639811,3272941872623831,5672,7782,9954,5109077676627801,1741,3771,5961,272651243516,3486,6636,5174,3134,3253,7083,752
       Goodwill 
0
0
0
0
893
905
0
0
0
5,467
4,910
11,660
6,071
5,266
4,541
3,826
15,363
15,363
15,363
10,821
10,821
10,821
10,821
10,821
10,821
10,821
10,821
4,544
4,544
0
0
2,115
2,115
2,115
2,115
2,1152,1152,1152,115004,5444,54410,82110,82110,82110,82110,82110,82110,82110,82115,36315,36315,3633,8264,5415,2666,07111,6604,9105,4670009058930000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30
30
30
30
30
178
2,885
51
148
0
0
00148512,8851783030303030000000000000000000000000
       Intangible Assets 
0
0
0
0
191
0
0
10,000
10,000
10,000
60
7,530
1,929
1,539
252
3,826
1,270
2,904
14
14
14
12,066
10,821
10,821
10,821
10,821
10,821
837
2,688
4,472
4,674
17,170
18,610
11,244
10,815
10,81511,24418,61017,1704,6744,4722,68883710,82110,82110,82110,82110,82112,0661414142,9041,2703,8262521,5391,9297,5306010,00010,00010,000001910000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
60
0
0
0
141
140
65
54
56
179
96
99
102
92
131
1,258
1,181
950
447
617
750
855
855
525
0
05258558557506174479501,1811,258131921029996179565465140141000600000000000
> Total Liabilities 
979
1,039
1,046
846
1,851
9,206
8,226
325
221
6,282
7,637
10,621
12,522
17,547
23,857
18,677
19,271
19,229
21,904
16,988
16,904
15,240
9,603
8,958
8,370
7,323
6,121
5,781
5,499
5,016
5,981
8,417
7,566
14,309
13,885
13,88514,3097,5668,4175,9815,0165,4995,7816,1217,3238,3708,9589,60315,24016,90416,98821,90419,22919,27118,67723,85717,54712,52210,6217,6376,2822213258,2269,2061,8518461,0461,039979
   > Total Current Liabilities 
766
1,039
1,046
846
1,851
8,394
8,044
291
196
6,259
2,494
9,701
12,290
16,415
23,330
12,030
12,424
7,881
21,678
16,752
13,540
14,363
9,215
8,615
7,835
6,993
5,835
5,554
5,230
4,817
5,478
6,387
5,114
12,290
11,950
11,95012,2905,1146,3875,4784,8175,2305,5545,8356,9937,8358,6159,21514,36313,54016,75221,6787,88112,42412,03023,33016,41512,2909,7012,4946,2591962918,0448,3941,8518461,0461,039766
       Short-term Debt 
0
0
0
0
0
796
246
0
0
0
0
0
0
4,024
9,706
2,557
6,854
469
11,742
6,919
2,786
2,650
0
0
0
0
0
0
0
0
422
280
303
32
0
032303280422000000002,6502,7866,91911,7424696,8542,5579,7064,02400000024679600000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
519
2,923
6,897
9,058
8,355
3,946
1,632
1,162
711
679
569
473
439
368
496
548
297
382
447
591
361
435
841
670
569
5696708414353615914473822975484963684394735696797111,1621,6323,9468,3559,0586,8972,9235190000000000
       Other Current Liabilities 
766
1,039
1,046
680
1,141
5,171
6,622
15
26
5,438
1,974
6,778
4,538
2,463
5,269
5,528
2,062
4,452
7,189
9,076
9,657
10,694
8,297
7,686
6,896
6,141
5,296
4,970
4,595
4,080
4,469
5,572
3,887
10,671
0
010,6713,8875,5724,4694,0804,5954,9705,2966,1416,8967,6868,29710,6949,6579,0767,1894,4522,0625,5285,2692,4634,5386,7781,9745,43826156,6225,1711,1416801,0461,039766
   > Long-term Liabilities 
213
0
0
0
0
812
182
34
25
23
5,143
920
232
1,132
527
6,647
6,847
11,348
226
236
3,364
877
388
343
535
330
286
227
269
199
503
2,030
2,452
2,019
1,935
1,9352,0192,4522,0305031992692272863305353433888773,36423622611,3486,8476,6475271,1322329205,1432325341828120000213
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
311
41
23
0
0
002341311000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
23
49
29
49
98
93
147
117
158
206
164
177
388
343
535
330
286
227
269
199
192
1,989
2,429
2,019
0
02,0192,4291,9891921992692272863305353433881771642061581171479398492949230000000000
> Total Stockholder Equity
4,305
4,874
5,585
5,760
8,097
5,401
2,418
17,477
14,375
11,751
265
12,955
1,177
-8,959
-13,538
-10,666
3,806
7,547
5,109
2,023
2,897
4,648
10,677
16,358
18,874
19,931
19,908
13,976
14,227
10,022
13,197
22,930
23,203
22,211
15,972
15,97222,21123,20322,93013,19710,02214,22713,97619,90819,93118,87416,35810,6774,6482,8972,0235,1097,5473,806-10,666-13,538-8,9591,17712,95526511,75114,37517,4772,4185,4018,0975,7605,5854,8744,305
   Common Stock
588
588
588
588
666
779
3,353
16,136
16,136
35,080
36,460
55,164
61,040
61,315
65,267
73,462
74,107
77,223
77,835
85,219
85,219
85,219
85,219
85,795
86,223
86,283
86,283
86,283
86,283
86,283
89,724
98,366
98,366
98,405
0
098,40598,36698,36689,72486,28386,28386,28386,28386,28386,22385,79585,21985,21985,21985,21977,83577,22374,10773,46265,26761,31561,04055,16436,46035,08016,13616,1363,353779666588588588588
   Retained Earnings 
1,382
1,950
2,063
2,238
2,156
-7,324
-14,332
-17,053
-20,156
-23,330
-36,195
-44,428
-62,068
-70,274
-78,805
-84,129
-70,314
-69,906
-73,027
-83,515
-82,577
-80,805
-74,772
-69,784
-68,462
-66,603
-66,465
-72,307
-72,056
-76,261
-76,545
-75,454
-75,202
-76,253
-78,022
-78,022-76,253-75,202-75,454-76,545-76,261-72,056-72,307-66,465-66,603-68,462-69,784-74,772-80,805-82,577-83,515-73,027-69,906-70,314-84,129-78,805-70,274-62,068-44,428-36,195-23,330-20,156-17,053-14,332-7,3242,1562,2382,0631,9501,382
   Capital Surplus 00000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000
   Other Stockholders Equity 
2,335
2,336
2,934
3,816
5,275
12,820
13,919
18,394
18,406
46
152
3,209
3,826
0
0
0
0
0
0
0
0
0
0
0
1,113
251
90
0
1,814
2,208
18
18
39
59
0
0593918182,2081,8140902511,113000000000003,8263,2091524618,40618,39413,91912,8205,2753,8162,9342,3362,335



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.




5.5. Cash Flows

Currency in AUD. All numbers in thousands.




5.6. Income Statements

Currency in AUD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue6,487
Cost of Revenue-1,234
Gross Profit5,2535,253
 
Operating Income (+$)
Gross Profit5,253
Operating Expense-0
Operating Income-1,3635,253
 
Operating Expense (+$)
Research Development-144
Selling General Administrative2,770
Selling And Marketing Expenses0
Operating Expense02,626
 
Net Interest Income (+$)
Interest Income294
Interest Expense-43
Other Finance Cost-0
Net Interest Income251
 
Pretax Income (+$)
Operating Income-1,363
Net Interest Income251
Other Non-Operating Income Expenses0
Income Before Tax (EBT)201-2,676
EBIT - interestExpense = -43
-1,769
-1,726
Interest Expense43
Earnings Before Interest and Taxes (EBIT)0244
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax201
Tax Provision-106
Net Income From Continuing Ops9595
Net Income-1,769
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net1,313-251
 

Technical Analysis of Pharmx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pharmx. The general trend of Pharmx is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pharmx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Pharmx Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pharmx Technologies Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.097.

The bearish price targets are: 0.088 > 0.085 > 0.085.

Know someone who trades $PHX? Share this with them.πŸ‘‡

Pharmx Technologies Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pharmx Technologies Ltd. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pharmx Technologies Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pharmx Technologies Ltd. The current macd is 0.00231631.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pharmx price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Pharmx. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Pharmx price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Pharmx Technologies Ltd Daily Moving Average Convergence/Divergence (MACD) ChartPharmx Technologies Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pharmx Technologies Ltd. The current adx is 25.20.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Pharmx shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Pharmx Technologies Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pharmx Technologies Ltd. The current sar is 0.09364.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Pharmx Technologies Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pharmx Technologies Ltd. The current rsi is 59.19. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
Pharmx Technologies Ltd Daily Relative Strength Index (RSI) ChartPharmx Technologies Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pharmx Technologies Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pharmx price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Pharmx Technologies Ltd Daily Stochastic Oscillator ChartPharmx Technologies Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pharmx Technologies Ltd. The current cci is -54.05405405.

Pharmx Technologies Ltd Daily Commodity Channel Index (CCI) ChartPharmx Technologies Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pharmx Technologies Ltd. The current cmo is 8.14221419.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Pharmx Technologies Ltd Daily Chande Momentum Oscillator (CMO) ChartPharmx Technologies Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pharmx Technologies Ltd. The current willr is -33.33333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Pharmx is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Pharmx Technologies Ltd Daily Williams %R ChartPharmx Technologies Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Pharmx Technologies Ltd.

Pharmx Technologies Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pharmx Technologies Ltd. The current atr is 0.00267717.

Pharmx Technologies Ltd Daily Average True Range (ATR) ChartPharmx Technologies Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pharmx Technologies Ltd. The current obv is 12,839,567.

Pharmx Technologies Ltd Daily On-Balance Volume (OBV) ChartPharmx Technologies Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pharmx Technologies Ltd. The current mfi is 39.03.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Pharmx Technologies Ltd Daily Money Flow Index (MFI) ChartPharmx Technologies Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pharmx Technologies Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-19BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Pharmx Technologies Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pharmx Technologies Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.194
Ma 20Greater thanMa 500.092
Ma 50Greater thanMa 1000.084
Ma 100Greater thanMa 2000.081
OpenGreater thanClose0.091
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Pharmx with someone you think should read this too:
  • Are you bullish or bearish on Pharmx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pharmx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pharmx Technologies Ltd

I send you an email if I find something interesting about Pharmx Technologies Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Pharmx Technologies Ltd.

Receive notifications about Pharmx Technologies Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.